Skip Navigation

AIDSInfo logo

 
Home > Drugs > Fosalvudine

Fosalvudine
Drug Class: Nucleoside Reverse Transcriptase Inhibitors
Fosalvudine is a type of medicine called a nucleoside reverse transcriptase inhibitor (NRTI). NRTIs block reverse transcriptase, a protein that HIV needs to make more copies of itself.

HIV/AIDS-Related Uses
Fosalvudine is an investigational medicine that is not yet approved by the FDA for use outside of clinical trials. It is being studied for the treatment of HIV infection.
This medicine does not cure or prevent HIV infection or AIDS and does not reduce the risk of passing the virus to other people.

Dosage Form/Administration
Fosalvudine is taken by mouth and is being studied in doses of 10 to 40 mg.



Contraindications
Individuals should tell a doctor about any medical problems before taking this medicine.

Possible Side Effects
Along with its desired effects, fosalvudine can cause some unwanted effects. Although not all of these effects are known, nausea, vomiting, diarrhea, and headache have been reported in an early study of fosalvudine in HIV-infected individuals. Individuals should tell a doctor if they have side effects.

Drug and Food Interactions
A doctor should be notified of any other medications being taken, including prescription, nonprescription (over-the-counter), or herbal medications.

Clinical Trials
Click here to search ClinicalTrials.gov for trials that use Fosalvudine.

Manufacturer Information
Fosalvudine
  Heidelberg Pharma
  Schriesheimer Strasse 101
  D-68526 Ladenburg
  Baden-Wurttemberg,  Germany
  49-6203-1009-40
    
Updated September 8, 2008